[1] 罗德云, 陈菊屏. NLR联合降钙素原对COPD急性加重期细菌感染患者预后价值探讨[J]. 天津医药, 2019, 47(10):1054-1057. [2] SHI T, FENG L. Blood biomarkers associated with acute type II respiratory failure in COPD: A meta-analysis[J]. Clin Respir J, 2022, 16(2):75-83. [3] PIRAINO T. Noninvasive respiratory support in acute hypoxemic respiratory failure[J]. Respir Care, 2019, 64(6):638-646. [4] 瞿奥林, 郭任维, 马明峰, 等. 中性粒细胞与淋巴细胞比值联合NT-proBNP评估慢性心力衰竭患者的短期预后价值[J]. 中国临床研究, 2019, 32(12):1632-1635. [5] DUIVERMAN M L, VONK J M, BLADDER G, et al. Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial[J]. Thorax, 2020, 75(3):244-252. [6] XU Z, ZHU L, ZHAN J, et al. The efficacy and safety of high-flow nasal cannula therapy in patients with COPD and type II respiratory failure: a meta-analysis and systematic review[J]. Eur J Med Res, 2021, 26(1):122. [7] 邓爱兵, 宋健, 王静, 等. 肺CT联合降钙素原,C反应蛋白检测对COPDⅡ型呼吸衰竭疗效,预后评估的临床价值[J]. 临床和实验医学杂志, 2021, 20(2):161-165. [8] TENG W, CHEN H, SHI S, et al. Effect of bilevel continuous positive airway pressure for patients with type II respiratory failure due to acute exacerbation of COPD: a protocol for systematic review and meta-analysis[J]. Medicine: Baltimore, 2021, 100(2):e24016. [9] THORVE S M, AWAD N T, NAIR J P, et al. Comparison in outcome of patients with post TB-destroyed lung and COPD admitted with respiratory failure[J]. J Assoc Physicians India, 2021, 69(7):11-12. [10] SHIMIZU K, TANABE N, THO N V, et al. Percent low attenuation volume and fractal dimension of low attenuation clusters on CT predict different long-term outcomes in COPD[J]. Thorax, 2020, 75(2):116-122. [11] EMAMI ARDESTAMI M, ALAVI-NAEINI N. Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Clin Respir J, 2021, 15(4):382-388. |